- Correction
- Open access
- Published:
Correction: Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
Molecular Cancer volume 22, Article number: 144 (2023)
The Original Article was published on 31 August 2014
Correction:Mol Cancer13, 203 (2014)
Unfortunately, the original version of this article [1] contained some errors. The words “binding” has been spelt incorrectly in the fifth title of result section and legend of Fig. 5. And the image of GAPDH (Fig. 6D) has been mistakenly uploaded. The mistakes did not affect any correctness of our results or discussion. The corrected sentence Fig. 6 was provided here. We regret any inconvenience that caused.
“CS-6 inhibited NF-κB and p300 translocation and binding to COX-2 promoter”. “Figure 5 CS-6 inhibited NF-κB and p300 translocation and their binding to COX-2 promoter”.
CS-6 inhibited the phosphorylation and activation of IKKβ.(D) A549 cells were treated with CS-6 (50 nM) after pretreatment with CB (50 nM). The IKKβ, and p-IKKβ proteins were analyzed by Western blotting.
References
Yu, Z., Guo, W., Ma, X. et al Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells. Mol Cancer13, 203 (2014). https://0-doi-org.brum.beds.ac.uk/10.1186/1476-4598-13-203
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://0-doi-org.brum.beds.ac.uk/10.1186/1476-4598-13-203
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yu, Z., Guo, W., Ma, X. et al. Correction: Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells. Mol Cancer 22, 144 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12943-023-01852-5
Published:
DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12943-023-01852-5